Turn Therapeutics Inc (TTRX)

Turn Therapeutics Inc. experienced consistent insider buying activity throughout late 2025. The most recent transactions occurred on December 12, 2025, when Zuraiz Chaudhary acquired shares. Other key participants, including Arthur F. Golden and Abraham Chesed, also increased their holdings during this period, reflecting a pattern of accumulation by company leadership across several months.
Ticker: TTRX Exchange: NMS


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Turn Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.9
Chaudhary Zuraiz See Remarks Officer
Transaction date
Purchase
Price
428.06
Quantity 169 -35.8%
Value US$4,869,563
3.4
GOLDEN ARTHUR F Non-Executive Director
Transaction date
Purchase
Price
446.42
Quantity 8,968 +24.2%
Value US$4,588,004
3.4
GOLDEN ARTHUR F Non-Executive Director
Transaction date
Purchase
Price
38.10
Quantity 14,908 +22.2%
Value US$4,839,736
1.9
Chaudhary Zuraiz See Remarks Officer
Transaction date
Purchase
Price
3.29
Quantity 1,000 +11.1%
Value US$3,290
1.9
Chaudhary Zuraiz See Remarks Officer
Transaction date
Purchase
Price
2.61
Quantity 1,450 +19.2%
Value US$3,784
1.9
Chaudhary Zuraiz See Remarks Officer
Transaction date
Purchase
Price
3.62
Quantity 2,500 +49.5%
Value US$9,050
Transaction date
Purchase
Price
4.60
Quantity 14,286 +1.0%
Value US$65,716
1.9
Chaudhary Zuraiz See Remarks Officer
Transaction date
Purchase
Price
4.95
Quantity 5,050 New position
Value US$24,998
3.4
GOLDEN ARTHUR F Non-Executive Director
Transaction date
Purchase
Price
4.95
Quantity 20,202 +202.0%
Value US$100,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2025-12-12 2025-12-12 B Purchase

See Remarks

Officer
169 -35.8%
428.06
US$4,869,563
169 -35.8% 428.06 US$4,869,563
2025-11-25 2025-11-24 B Purchase Non-Executive Director
8,968 +24.2%
446.42
US$4,588,004
8,968 +24.2% 446.42 US$4,588,004
2025-11-24 2025-11-21 B Purchase Non-Executive Director
14,908 +22.2%
38.10
US$4,839,736
14,908 +22.2% 38.10 US$4,839,736
2025-11-21 2025-11-21 B Purchase

See Remarks

Officer
1,000 +11.1%
3.29
US$3,290
1,000 +11.1% 3.29 US$3,290
2025-11-21 2025-11-20 B Purchase

See Remarks

Officer
1,450 +19.2%
2.61
US$3,784
1,450 +19.2% 2.61 US$3,784
2025-11-17 2025-11-17 B Purchase

See Remarks

Officer
2,500 +49.5%
3.62
US$9,050
2,500 +49.5% 3.62 US$9,050
2025-10-29 2025-10-23 B Purchase
14,286 +1.0%
4.60
US$65,716
14,286 +1.0% 4.60 US$65,716
2025-10-23 2025-10-23 B Purchase

See Remarks

Officer
5,050 New position
4.95
US$24,998
5,050 New position 4.95 US$24,998
2025-10-23 2025-10-23 B Purchase Non-Executive Director
20,202 +202.0%
4.95
US$100,000
20,202 +202.0% 4.95 US$100,000